Pricing Log in Create free account

BioStem Technologies, Inc. (BSEM) vs Estrella Immunopharma, Inc. (ESLA)

BioStem Technologies, Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. BioStem Technologies, Inc. and Estrella Immunopharma, Inc. are of similar size ($19.4M and $17.8M). Estrella Immunopharma, Inc. has the higher net margin (0.00% vs −76.0%) and the lower return on invested capital (0.00% vs 55.3%). Across the 10 metrics below, BioStem Technologies, Inc. leads on 7 and Estrella Immunopharma, Inc. on 3.

Valuation

Metric BSEM ESLA Biotechnology median
P/E n/m n/m 10.60
P/S 0.56 n/m 9.40
P/B 0.70 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.68 n/m 0.66
EV/Sales 0.36 n/m 9.02
Earnings yield (137.92%) (65.92%) (32.88%)
Free cash flow yield 0.00% (58.98%) (23.13%)

Profitability

Metric BSEM ESLA Biotechnology median
Gross margin 91.16% — 68.51%
Operating margin 52.87% 0.00% 0.00%
Net margin (76.02%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 148.05% (51.96%)
Return on assets 0.00% (416.74%) (46.06%)
Return on invested capital 55.34% 0.00% 0.00%

Growth

Metric BSEM ESLA Biotechnology median
Revenue growth (TTM) (87.14%) — 6.76%
EPS growth (last fiscal year) (126.53%) (188.78%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BSEM ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.98 0.20 4.97
Net debt to EBITDA 0.00 0.11 1.01

Dividend

Metric BSEM ESLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BSEM ESLA Biotechnology median
Market cap 19.42m 17.84m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack